John Arena, interim president of global pharma services at Cencora, discusses the importance of engaging with partners as ...

Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at ...

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...

Valencia will seek to leverage the investment as well as Surek’s leadership experience to drive commercialization of its ...

Under terms of the deal, Stoke will spearhead global development of zorevunersen, while Biogen will receive exclusive rights ...

Led by Bosch Ventures, Applyo Jena’s Series A funding seeks to accelerate the development and commercialization of its ...

Last week, the Trump administration ordered all federal agencies to lay off all probationary workers. As a result, hundreds ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for improving glycemic control ...

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...